Physician profile
William M Meadows
NPI 1780614198
$802.53
in general payments reported to CMS, 2019-2025
11 companies · $54.61 in 2025
The $54.61 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.34 · 2020: $31.60 · 2021: $77.30 · 2022: $41.20 · 2023: $197 · 2024: $372 · 2025: $54.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.67 | 2021-2024 | |
| Smith+Nephew, INC. | $179.44 | 2020-2023 | Renasys Go V2 Home |
| Urgo Medical North America, LLC | $99.66 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Kci USA, INC. | $48.50 | 2022-2023 | Activ.A.C. Ion Progress, Promogran |
| E.R. Squibb & Sons, L.L.C. | $36.70 | 2025 | Eliquis |
| Solventum Corporation | $23.29 | 2024 | Activ.A.C. |
| Convatec INC. | $19.60 | 2021 | |
| Ossur Americas, INC. | $17.91 | 2025 | |
| Mckesson Patient Care Solutions INC. | $17.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.42 | 2023 | Nuzyra |
| Allergan, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.